Platnium Plated Pills
Well, considering the prices, they may well be made of platnium. Or diamonds. And you know what I’m talking about if you take prescription drugs, and happen to have the misfortune of not having health insurance or a piddly drug plan–and have double the misfortune of not living in a border state. You know, like scooting down to Tijuana to fill up on your Retin-A and Lipitor, or heading up north to Toronto to make a similar score.
Here’s the sad truth: Americans pay more for brand-name prescription drugs than anyone else in the world. Isn’t that a dubious honor. It assumes that either we are all very wealthy and don’t notice the missing cash in our wallets, or else we enjoy being ripped off.
From CBSnews.com:
Why? Well, the drug companies and the government say we have to, so the companies can keep developing new drugs.
But that’s no consolation to the tens of millions of elderly and uninsured who can’t afford to pay for the drugs they need. Correspondent Bob Simon talks Dr. Peter Rost, a critic of the way drugs are priced and sold in the United States, who also happens to be a vice president of marketing for the pharmaceutical giant Pfizer.
Rost has taken the risky and possibly career-shattering step of opposing his own employer, and the rest of the drug industry, by saying America can have cheaper drugs if it set up a system like the one in Europe.
Now see if these prices don’t set you in a tizzy. Yo, you lipitor users–read this and weep. The commonly prescribed cholesterol-lowering drug Lipitor, made by Pfizer, the company he works for. In the United States, the full retail price is about $76 dollars for a month’s supply. The exact same drug costs $55 dollars in Canada and just $43 dollars in Italy.
The price in Italy in almost half of what it sells for here, and I bet it’s even lower in Mexico.
Rost argues patients shouldn’t have to travel to other countries to obtain cheaper drugs, but rather the discounted drugs should come to them. That’s what happens in Europe …
In Europe, pharmaceutical companies sell the exact same drug to different countries at different prices. An entire industry has been created that buys up drugs in countries where they are cheaper and then repackages and sells them in countries where they’re more expensive, at a discount — this is known as parallel trading.
However, American drug makers want no part of that system, and Pfizer, in a statement by its vice president of global security, said the practice can be potentially dangerous. However, when asked if anyone had been harmed by this method of selling drugs in Europe, the Pfizer VP couldn’t recall a single incident.
Rost argues that America’s views on parallel trading are clearly a matter of profits, not a matter of safety.
A bill has been introduced in the Senate that, if passed, would allow the United States to import cheaper drugs from other countries like Europe does. While the pharmaceutical industry opposes it, large drug companies have announced they are expanding their programs to offer low-cost drugs to the poor.
I guess things are going to keep cooking. It’s quite interesting that Rost works for Pfizer (or does he still have a job?) and has been so vocal and active in trying to change the system, which will inevitably cause pharm companies to lose some revenue.


Today is the summer solstice, the longest day of the year. Midsummer’s night eve. Enjoy it, because now the days will start to get shorter!